Departamento de Nutrición y Bromatología II, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain.
Instituto de Estudios Biofuncionales, Departamento de Química Física II, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Carbohydr Polym. 2016 Feb 10;137:617-624. doi: 10.1016/j.carbpol.2015.11.011. Epub 2015 Nov 10.
Chitosan with high number of deacetylated units, its reacetylated derivative and COS obtained through an enzymatic treatment with chitosanase were tested in pH controlled batch cultures to investigate the ability of the human faecal microbiota to utilise them. Chitosan derivatives with high number of deacetylated units decreased the bacterial populations: Bifidobacterium spp., Eubacterium rectale/Clostridium coccoides, C. Histolyticum and Bacteroides/Prevotella. On the other hand, chitosan derivatives with high content of acetylated residues maintained the tested bacterial groups and could increase Lactobacillus/Enterococcus. Regarding short chain fatty acids (SCFA), only low Mw COS increased the production in similar levels than fructo-oligossacharides (FOS). The acetylated chitosans and their COS do not appear as potential prebiotics but did not affect negatively the faecal microbiota, while derivatives with high number of deacetylated units could induce a colonic microbiota imbalance.
壳聚糖及其高脱乙酰度的再乙酰化衍生物和壳聚糖酶酶解得到的 COS ,在 pH 控制的分批培养中进行了测试,以研究人肠道微生物群利用它们的能力。高脱乙酰度的壳聚糖衍生物降低了细菌种群:双歧杆菌属、真杆菌/梭菌 coccoides、C. Histolyticum 和拟杆菌/普雷沃氏菌。另一方面,高乙酰化残基的壳聚糖衍生物保持了测试的细菌群,并且可以增加乳杆菌/肠球菌。关于短链脂肪酸 (SCFA),只有低分子量的 COS 增加了与果寡糖 (FOS)相似水平的产生。乙酰化壳聚糖及其 COS 似乎不是潜在的益生元,但不会对肠道微生物群产生负面影响,而高脱乙酰度的衍生物可能会导致结肠微生物群失衡。